Hofseth Biocare Asa Stock Net Income
HBC Stock | NOK 2.03 0.03 1.46% |
Hofseth Biocare ASA fundamentals help investors to digest information that contributes to Hofseth Biocare's financial success or failures. It also enables traders to predict the movement of Hofseth Stock. The fundamental analysis module provides a way to measure Hofseth Biocare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hofseth Biocare stock.
Hofseth |
Hofseth Biocare ASA Company Net Income Analysis
Hofseth Biocare's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Hofseth Biocare Net Income | (126.46 M) |
Most of Hofseth Biocare's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hofseth Biocare ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Hofseth Biocare ASA reported net income of (126.46 Million). This is 137.06% lower than that of the Healthcare sector and 280.54% lower than that of the Biotechnology industry. The net income for all Norway stocks is 122.15% higher than that of the company.
Hofseth Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hofseth Biocare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hofseth Biocare could also be used in its relative valuation, which is a method of valuing Hofseth Biocare by comparing valuation metrics of similar companies.Hofseth Biocare is currently under evaluation in net income category among related companies.
Hofseth Fundamentals
Return On Equity | -0.95 | |||
Return On Asset | -0.19 | |||
Profit Margin | (1.14) % | |||
Operating Margin | (1.07) % | |||
Current Valuation | 1.03 B | |||
Shares Outstanding | 395.08 M | |||
Shares Owned By Insiders | 52.50 % | |||
Shares Owned By Institutions | 20.43 % | |||
Price To Earning | (4.13) X | |||
Price To Book | 5.19 X | |||
Price To Sales | 8.29 X | |||
Revenue | 87.62 M | |||
Gross Profit | 28.51 M | |||
EBITDA | (87.72 M) | |||
Net Income | (126.46 M) | |||
Cash And Equivalents | 36.52 M | |||
Cash Per Share | 0.12 X | |||
Total Debt | 123.31 M | |||
Debt To Equity | 188.20 % | |||
Current Ratio | 1.11 X | |||
Book Value Per Share | 0.39 X | |||
Cash Flow From Operations | (61.78 M) | |||
Earnings Per Share | (0.38) X | |||
Beta | 0.54 | |||
Market Capitalization | 1.1 B | |||
Total Asset | 415.97 M | |||
Retained Earnings | (105 M) | |||
Working Capital | (22 M) | |||
Current Asset | 52 M | |||
Current Liabilities | 74 M | |||
Z Score | 4.8 | |||
Net Asset | 415.97 M |
About Hofseth Biocare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hofseth Biocare ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hofseth Biocare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hofseth Biocare ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hofseth Biocare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hofseth Biocare's short interest history, or implied volatility extrapolated from Hofseth Biocare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hofseth Biocare ASA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Hofseth Biocare ASA information on this page should be used as a complementary analysis to other Hofseth Biocare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Hofseth Stock analysis
When running Hofseth Biocare's price analysis, check to measure Hofseth Biocare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hofseth Biocare is operating at the current time. Most of Hofseth Biocare's value examination focuses on studying past and present price action to predict the probability of Hofseth Biocare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hofseth Biocare's price. Additionally, you may evaluate how the addition of Hofseth Biocare to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |